Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BTG acquires chemical tool to ease surgery:

This article was originally published in Clinica

Executive Summary

UK firm BTG has acquired the rights to a new surgical tool that allows tissue to be cut much more easily. Developed for surgery by researchers at the University of Parma, Italy, MESNA (sodium-2-mercaptoethane sulphate) is a chemical dissection agent that breaks molecular bonds in tissues, allowing cancerous and normal tissue to be separated more easily. It has currently only been trialled in animals, where it was found to be effective in preventing and treating capsular formation in plastic surgery and reducing trauma to the tissue. The London- based firm said it would continue work to validate the tool.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063893

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel